| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000068315.98705.CC |
| P698 | PubMed publication ID | 12719280 |
| P50 | author | Me Kooi | Q43106459 |
| Mat J A P Daemen | Q73172570 | ||
| P2093 | author name string | M Borgers | |
| P M Frederik | |||
| A G H Kessels | |||
| J M A van Engelshoven | |||
| P J E H M Kitslaar | |||
| V C Cappendijk | |||
| K B J M Cleutjens | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | iron | Q677 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 2453-2458 | |
| P577 | publication date | 2003-04-28 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging | |
| P478 | volume | 107 |
| Q35896196 | (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study |
| Q51786439 | (89) Zr- and Fe-Labeled Polymeric Micelles for Dual Modality PET and T1 -Weighted MR Imaging. |
| Q36336344 | 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles. |
| Q36329223 | 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. |
| Q79538242 | 99mTc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits |
| Q35967907 | A Review of Clinical Translation of Inorganic Nanoparticles. |
| Q36301599 | A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging |
| Q34479292 | A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis |
| Q39991136 | A novel magnetic approach to enhance the efficacy of cell-based gene therapies |
| Q51608260 | A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent. |
| Q79279173 | Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques |
| Q36986368 | Advances in atheroma imaging in the carotid |
| Q30441467 | Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage. |
| Q83435629 | Advances in imaging angiogenesis and inflammation in atherosclerosis |
| Q38052020 | Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. |
| Q37284563 | Advances in molecular imaging of atherosclerotic vascular disease |
| Q48696576 | Allometric scaling of wall shear stress from mice to humans: quantification using cine phase-contrast MRI and computational fluid dynamics |
| Q55516366 | Application of Light Scattering Techniques to Nanoparticle Characterization and Development. |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q34987701 | Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT. |
| Q50175626 | Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging |
| Q37663672 | Bioabsorbable stent quo vadis: a case for nano-theranostics |
| Q58910334 | Biocompatibility and Toxicity of Nanoparticles and Nanotubes |
| Q39832600 | Biodistribution of polyacrylic acid-coated iron oxide nanoparticles is associated with proinflammatory activation and liver toxicity |
| Q37228234 | Biological imaging of atherosclerosis: moving beyond anatomy |
| Q55086947 | Biological responses to core-shell-structured Fe3O4@SiO2-NH2 nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy. |
| Q36867008 | Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque. |
| Q37762507 | Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. |
| Q40373160 | CD4+CD28null T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis |
| Q34564399 | CMR assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset. |
| Q37656278 | Cardiovascular MRI in small animals |
| Q33592226 | Cardiovascular magnetic resonance in carotid atherosclerotic disease |
| Q37530107 | Cardiovascular molecular imaging: an overview |
| Q30470859 | Cardiovascular molecular imaging: focus on clinical translation |
| Q37821913 | Carotid MRI: a tool for monitoring individual response to cardiovascular therapy? |
| Q36417897 | Carotid artery disease and stroke: assessing risk with vessel wall MRI. |
| Q42428121 | Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction |
| Q37209833 | Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease |
| Q89556307 | Cellular uptake of magnetic nanoparticles imaged and quantified by magnetic particle imaging |
| Q36580339 | Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics |
| Q33752929 | Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines |
| Q45739358 | Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability |
| Q57814135 | Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers |
| Q89798553 | Clinical imaging of cardiovascular inflammation |
| Q38742857 | Clinical imaging of vascular disease in chronic kidney disease |
| Q35611079 | Compensatory UTE/T2W Imaging of Inflammatory Vascular Wall in Hyperlipidemic Rabbits |
| Q35627335 | Complementary results of computed tomography and magnetic resonance imaging of the heart and coronary arteries: a review and future outlook |
| Q42114662 | Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization |
| Q34404461 | Contribution of cardiovascular magnetic resonance in the evaluation of coronary arteries |
| Q33822630 | Controlled assembly of biodegradable plasmonic nanoclusters for near-infrared imaging and therapeutic applications |
| Q37462399 | Coronary CT angiography (CCTA) and advances in CT plaque imaging |
| Q36245223 | Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis. |
| Q30839550 | Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality |
| Q30448145 | Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI). |
| Q38573781 | Detecting the vulnerable plaque in patients |
| Q38848673 | Detection and treatment of atherosclerosis using nanoparticles |
| Q41365604 | Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI. |
| Q36396054 | Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles |
| Q35080574 | Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography |
| Q37076295 | Diagnosis and treatment of coronary vulnerable plaques |
| Q39976020 | Diagnostic accuracy of colour Doppler ultrasonography, CT angiography and blood-pool-enhanced MR angiography in assessing carotid stenosis: a comparative study with DSA in 170 patients. |
| Q36382488 | Differential response of macrophages to core-shell Fe3O4@Au nanoparticles and nanostars |
| Q37709428 | Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management |
| Q37390765 | Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease |
| Q38224182 | Emerging applications for ferumoxytol as a contrast agent in MRI. |
| Q30475719 | Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases |
| Q33839384 | Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques |
| Q30450437 | Emerging diagnostic and therapeutic molecular imaging applications in vascular disease |
| Q38013147 | Emerging engineered magnetic nanoparticulate probes for targeted MRI of atherosclerotic plaque macrophages |
| Q36759502 | Emerging nanomedicine opportunities with perfluorocarbon nanoparticles |
| Q90015714 | Emerging techniques in atherosclerosis imaging |
| Q27026602 | Enzyme immobilization: an update |
| Q42543316 | Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques |
| Q37431535 | Equilibrium gold nanoclusters quenched with biodegradable polymers |
| Q38507723 | Equivalence testing in microarray analysis: similarities in the transcriptome of human atherosclerotic and nonatherosclerotic macrophages. |
| Q38067325 | Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography |
| Q39343765 | Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findings |
| Q40120520 | Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. |
| Q37370204 | Fast low-angle positive contrast steady-state free precession imaging of USPIO-labeled macrophages: theory and in vitro experiment. |
| Q37165155 | Form to function: current and future roles for atherosclerosis imaging in drug development |
| Q36731084 | Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles |
| Q30533932 | Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance |
| Q41871940 | Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths |
| Q37001580 | Future non-invasive imaging to detect vascular plaque instability and subclinical non-obstructive atherosclerosis |
| Q34563944 | Gadolinium(III)-gold nanorods for MRI and photoacoustic imaging dual-modality detection of macrophages in atherosclerotic inflammation |
| Q38094125 | Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis. |
| Q57366614 | Gold nanoparticles with high densities of small protuberances on nanocluster cores with strong NIR extinction |
| Q45010830 | Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients |
| Q34412168 | High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis |
| Q56986839 | Identification of interleukin-2 for imaging atherosclerotic inflammation |
| Q38875478 | Imaging Atherosclerotic Plaque Calcification: Translating Biology |
| Q27002916 | Imaging and nanomedicine in inflammatory atherosclerosis |
| Q30435383 | Imaging atherosclerosis and vulnerable plaque |
| Q51945900 | Imaging biomarkers of atherosclerosis. |
| Q34109961 | Imaging biomarkers of cardiovascular disease |
| Q35588094 | Imaging in the evaluation of the patient with suspected acute coronary syndrome |
| Q34399530 | Imaging macrophages with nanoparticles |
| Q64286783 | Imaging modalities to diagnose carotid artery stenosis: progress and prospect |
| Q44183906 | Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI. |
| Q36410607 | Imaging of atherosclerosis using magnetic resonance: state of the art and future directions |
| Q37407240 | Imaging of the unstable plaque: how far have we got? |
| Q39278396 | Imaging pathobiology of carotid atherosclerosis with ultrasmall superparamagnetic particles of iron oxide: an update |
| Q36892171 | Imaging techniques for the vulnerable coronary plaque. |
| Q37244485 | Imaging the cellular biology of the carotid plaque. |
| Q30448146 | Improving quantification of intravascular fluorescence imaging using structural information |
| Q36289257 | In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles |
| Q27316888 | In vivo detection of macrophage recruitment in hind-limb ischemia using a targeted near-infrared fluorophore |
| Q37440349 | In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods |
| Q37157569 | In vivo molecular imaging of vascular stress |
| Q37668307 | In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging |
| Q27692593 | Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets |
| Q33719461 | Inflammation imaging in atherosclerosis |
| Q35676964 | Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study |
| Q42111724 | Inhaled Nanoparticles Accumulate at Sites of Vascular Disease |
| Q30744971 | Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images. |
| Q28384965 | Introduction to metallic nanoparticles |
| Q92565797 | Iron oxide nanoparticles promote vascular endothelial cells survival from oxidative stress by enhancement of autophagy |
| Q26830874 | Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation |
| Q37281417 | Kinetic assembly of near-IR-active gold nanoclusters using weakly adsorbing polymers to control the size |
| Q58795982 | Large T contrast enhancement using superparamagnetic nanoparticles in ultra-low field MRI |
| Q50567621 | Localization of deoxyglucose and annexin A5 in experimental atheroma correlates with macrophage infiltration but not lipid deposition in the lesion |
| Q33531262 | MR plaque imaging of the carotid artery |
| Q37103699 | MR-optical imaging of cardiovascular molecular targets |
| Q37284707 | MRI detection of single particles for cellular imaging. |
| Q26785603 | MRI for Crohn's Disease: Present and Future |
| Q30414516 | MRI of atherosclerosis: diagnosis and monitoring therapy |
| Q33922492 | MRI of carotid atherosclerosis |
| Q80969834 | MRI of carotid atherosclerosis |
| Q37681303 | MRI of carotid atherosclerosis: clinical implications and future directions |
| Q57185167 | MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis |
| Q38269856 | MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits |
| Q28648415 | MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery-the MA(3)RS study |
| Q36760572 | MRI versus CT for the detection of coronary artery disease: current state and future promises |
| Q33847006 | Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics |
| Q37294955 | Macrophages heterogeneity in atherosclerosis - implications for therapy. |
| Q26825052 | Macrophages in vascular inflammation--From atherosclerosis to vasculitis |
| Q43582691 | Magnetic Iron Oxide Nanoparticles as T2 MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell |
| Q36240507 | Magnetic Particle Imaging (MPI): Experimental Quantification of Vascular Stenosis Using Stationary Stenosis Phantoms |
| Q37474978 | Magnetic [corrected] resonance imaging [corrected] features of the disruption-prone and the disrupted carotid plaque |
| Q37002415 | Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications |
| Q37192908 | Magnetic nanoparticles in MR imaging and drug delivery. |
| Q26827983 | Magnetic particle imaging (MPI) for NMR and MRI researchers |
| Q27003403 | Magnetic resonance coronary angiography: where are we today? |
| Q35739811 | Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque |
| Q36050403 | Magnetic resonance imaging of atherosclerosis |
| Q42726387 | Magnetic resonance imaging of cells in experimental disease models |
| Q35980840 | Magnetic resonance molecular imaging with nanoparticles |
| Q36216849 | Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy |
| Q36304339 | Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis |
| Q38796404 | Molecular Cardiovascular Magnetic Resonance: Current Status and Future Prospects |
| Q91690483 | Molecular Imaging in Ischemic Heart Disease |
| Q54967787 | Molecular Imaging of Atherosclerosis: A Clinical Focus. |
| Q37478426 | Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents |
| Q40509301 | Molecular MRI of Inflammation in Atherosclerosis |
| Q38162728 | Molecular MRI of atherosclerosis. |
| Q37782254 | Molecular diagnostics in transplantation. |
| Q30484224 | Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation |
| Q37557366 | Molecular imaging in cardiovascular disease: targets and opportunities |
| Q37002432 | Molecular imaging in cardiovascular magnetic resonance imaging: current perspective and future potential |
| Q27027613 | Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents |
| Q41819473 | Molecular imaging of atherosclerosis: clinical state-of-the-art |
| Q50072823 | Molecular imaging of atherosclerosis: spotlight on Raman spectroscopy and surface-enhanced Raman scattering. |
| Q36095916 | Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic |
| Q30479243 | Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? |
| Q41782452 | Molecular imaging of innate immune cell function in transplant rejection |
| Q38043973 | Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice |
| Q38542308 | Molecular magnetic resonance imaging of atherosclerotic vessel wall disease. |
| Q21129471 | Molecular magnetic resonance imaging of brain-immune interactions |
| Q47114838 | Molecular targets in aortic aneurysm for establishing novel management paradigms |
| Q35936423 | Molecular, cellular and functional imaging of atherothrombosis |
| Q42076960 | Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. |
| Q51546997 | Motion-sensitized driven equilibrium for blood-suppressed T2* mapping. |
| Q41990984 | Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies |
| Q36545276 | Multimodal iron oxide nanoparticles for hybrid biomedical imaging |
| Q30438207 | Multimodality cardiovascular molecular imaging, Part II |
| Q37222159 | Multimodality nanotracers for cardiovascular applications. |
| Q35681183 | Nanomedical Theranostics in Cardiovascular Disease. |
| Q38034812 | Nanomedicine in cardiovascular therapy: recent advancements |
| Q30481471 | Nanomedicine strategies for molecular targets with MRI and optical imaging. |
| Q36651592 | Nanomedicines for Endothelial Disorders |
| Q43153036 | Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. |
| Q35667247 | Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases |
| Q57116116 | Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches |
| Q33632651 | Nanoparticles of a different source induce different patterns of activation in key biochemical and cellular components of the host response |
| Q37789182 | Nanotechnology and its Relationship to Interventional Radiology. Part I: Imaging |
| Q38089761 | Nanotechnology in the diagnosis of atherosclerotic disease |
| Q91583844 | Non-Invasive Photoacoustic Imaging of In Vivo Mice with Erythrocyte Derived Optical Nanoparticles to Detect CAD/MI |
| Q42339164 | Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. |
| Q35172896 | Non-invasive detection of vulnerable coronary plaque |
| Q27020959 | Non-invasive vulnerable plaque imaging: how do we know that treatment works? |
| Q37082503 | Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis |
| Q31167048 | Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging |
| Q52578262 | Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. |
| Q26772106 | Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification |
| Q40624169 | Novel particulate spin probe for targeted determination of oxygen in cells and tissues |
| Q33368024 | Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies |
| Q37440343 | Optical and multimodality molecular imaging: insights into atherosclerosis |
| Q37417701 | Pathophysiology of coronary artery disease: the case for multiparametric imaging. |
| Q30455490 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis. |
| Q27025494 | Polysaccharide nanosystems for future progress in cardiovascular pathologies |
| Q36792762 | Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms |
| Q57341103 | Progress of Nanobiomaterials for Theranostic Systems |
| Q47565083 | Propensity of a single-walled carbon nanotube-peptide to mimic a KK10 peptide in an HLA-TCR complex. |
| Q34861181 | Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. |
| Q34330885 | Quantitative cardiovascular magnetic resonance for molecular imaging |
| Q50187007 | Quantitative histochemistry for macrophage biodistribution on mice liver and spleen after the administration of a pharmacological-relevant dose of polyacrylic acid-coated iron oxide nanoparticles |
| Q34912643 | Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT |
| Q30577193 | Radiolabelled probes for imaging of atherosclerotic plaques. |
| Q37196226 | Radionuclide imaging: a molecular key to the atherosclerotic plaque |
| Q39211367 | Rapid binding of electrostatically stabilized iron oxide nanoparticles to THP-1 monocytic cells via interaction with glycosaminoglycans |
| Q50216735 | Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles. |
| Q38102018 | Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research |
| Q38233595 | Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging. |
| Q37670691 | Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI part III. |
| Q57382895 | Shell matters: Magnetic targeting of SPIONs and in vitro effects on endothelial and monocytic cell function |
| Q36361995 | Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages |
| Q90328748 | Single-Photon Emission Computed Tomography Imaging Using Formyl Peptide Receptor 1 Ligand Can Diagnose Aortic Aneurysms in a Mouse Model |
| Q37638513 | Superparamagnetic Nanoparticles for Atherosclerosis Imaging |
| Q38425098 | Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging. |
| Q37787083 | Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation |
| Q38815957 | Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI. |
| Q37222192 | Targeted imaging of myocardial damage |
| Q34982799 | Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. |
| Q38056019 | Targeted molecular imaging of vascular inflammation in cardiovascular disease using nano- and micro-sized agents |
| Q33901726 | Targeted probes for cardiovascular MRI |
| Q36090166 | Targeting the vulnerable plaque: the evolving role of nuclear imaging |
| Q36304170 | Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging |
| Q51848005 | Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaques. |
| Q26773129 | The Role of MR Enterography in Assessing Crohn's Disease Activity and Treatment Response |
| Q38800754 | The future of imaging in cardiovascular disease intervention trials: 2017 and beyond |
| Q53483658 | The popcorn plaques. |
| Q53638505 | The role of cardiovascular magnetic resonance in the non-invasive imaging of the atherosclerotic plaque. |
| Q37820086 | The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions. |
| Q30975449 | The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system |
| Q54985361 | Towards clinically translatable in vivo nanodiagnostics. |
| Q38072037 | Toxicology and clinical potential of nanoparticles |
| Q37455363 | Tracking immune cells in vivo using magnetic resonance imaging |
| Q83577942 | USPIO-enhanced magnetic resonance imaging of the knee in asymptomatic volunteers |
| Q57122928 | Ultrasmall superparamagnetic iron oxide nanoparticle uptake as noninvasive marker of aortic wall inflammation on MRI: proof of concept study |
| Q57603322 | Uptake of citrate-coated iron oxide nanoparticles into atherosclerotic lesions in mice occurs via accelerated transcytosis through plaque endothelial cells |
| Q33525255 | Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence |
| Q38595475 | Use of ultrasmall superparamagnetic iron oxide particles for imaging carotid atherosclerosis |
| Q53258247 | Utility of contrast-enhanced ultrasonography for qualitative imaging of atherosclerosis in Watanabe heritable hyperlipidemic rabbits: initial experimental study |
| Q37458797 | Vascular Imaging With Ferumoxytol as a Contrast Agent. |
| Q26783581 | Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxide |
| Q47794497 | Vessel wall characterization using quantitative MRI: what's in a number? |
| Q36632443 | What are the most useful and trustworthy noninvasive anatomic markers of existing vascular disease? |
| Q39290073 | When should we use contrast material in cardiac MRI? |
| Q79449729 | [Advances in cardiovascular medicine through molecular imaging] |
| Q81072339 | [High resolution MRI of carotid atherosclerosis: looking beyond the arterial lumen] |
| Q79488866 | [Molecular and parametric imaging with iron oxides] |
| Q84057017 | [State of the art: high resolution MR imaging of carotid atherosclerotic plaque] |
Search more.